BRISTOL-MYERS SQUIBB CANADA CO. ET AL. v. APOTEX ET AL.
Summary of A-106-17
The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.
Federal Court Type: Appeal (S.27 - Final) - Patent Act
Detected Type: Appeal (S.27 - Final) - Patent Act [from T-1100-15 - S. 18.1 Patented Medicines (Notice of Compliance) Regulations]
Parties and Lawyers:| Party | Firm | Lawyer |
|---|---|---|
| APOTEX INC | ||
| BRISTOL MYERS SQUIBB CANADA COMPANY | McCarthy Tétrault LLP | MASON, STEVEN G |
| BRISTOL MYERS SQUIBB HOLDINGS IRELAND | ||
| MINISTER OF HEALTH (THE) |
| Name | Number |
|---|---|
| 932 PATENT | |
| 898 PATENT | |
| 778 PATENT |
Patented Medicine: Dasatinib (Medicinal ingredients are based on automated analysis and should not be relied upon.)
Decisions
| Name | Date | Paragraph |
| Bristol-Myers Squibb Canada Co. v. Apotex Inc. 2017 FCA 190 | Sep 18, 2017 | For the reasons set out below and in light of the Supreme Court of Canada’s decision in Esomeprazole, I believe that the Federal Court’s determination regarding the lack of utility of claim 27 in the 932 patent cannot stand and that, accordingly, this appeal must be granted in respect of the 932 patent. As concerns the 898 patent, on the other hand, I do not believe that the Federal Court made a reviewable error in concluding that claims 1 and 3 of that patent were obvious. This finding is sufficient to uphold the Federal Court’s dismissal of the prohibition application in respect of the 898 patent and, as BMS concedes, it is unnecessary to examine the ground of appeal relating to double patenting. It follows that I would allow this appeal in part, set aside the judgment of the Federal Court in respect of the 932 patent and, making the decision it ought to have made, would issue an order of prohibition against the Minister of Health, prohibiting the issuance of an NOC to Apotex for its APO-Dasatinib product until the 932 patent expires. As success is divided, I would order that each party bear its own costs before this Court and the Federal Court. |
This is an appeal from 2017 FC 296 in T-1100-15. [Determination of the appeal is based on automated analysis and should not be relied upon.]
Docket Summary (Google Translate to English)
() 2019-11-28 - OttawaMemorandum to file from the Registry of the FCA dated 28-NOV-2019 transmitting a copy of the Order of the Court dated November 27, 2019 to the Prothonotary Milczynski and the Applications section of the FC placed on file.
Acknowledgment of Receipt received from all parties (by email) with respect to the Order of the Court dated November 27, 2019 placed on file on 28-NOV-2019
Order dated 27-NOV-2019 rendered by The Honourable Mr. Justice Webb The Honourable Mr. Justice Near The Honourable Madam Justice Gleason Matter considered without personal appearance The Court's decision is with regard to the motion / document number 40 Result: granted "... the order of prohibition against the Minister of Health, prohibiting the issuance of a Notice of Compliance to Apotex for its APO-Desatinib product until the Canadian Patent No. 2,366,932 expires is hereby set aside." Filed on 27-NOV-2019 entered in J. & O. Book, volume 310 page(s) 96 - 97
Communication from Registry to Judicial Administrator dated 22-NOV-2019 re: DOC 40
Acknowledgment of Receipt received from all parties (by email) with respect to the direction of the Court dated November 20, 2019 placed on file on 21-NOV-2019
Solicitor's certificate of service on behalf of Jerry Topolski confirming service of Doc. 44 upon Appellants and Respondent (The Minister of Health) by personal service on 21-NOV-2019 filed on 21-NOV-2019
Motion Record containing the following original document(s): 40 41 42 43 Number of copies received: 3 on behalf of Respondent (Apotex Inc.) filed on 21-NOV-2019
Written representations contained within a Motion Record on behalf of Respondent (Apotex Inc.) in support of Doc. 40 filed on 21-NOV-2019
Consent to the Order on behalf of Respondent (Apotex Inc.) filed on 21-NOV-2019
Affidavit of Harry Radomski contained within a Motion Record on behalf of Respondent (Apotex Inc.) sworn on 21-NOV-2019 in support of Doc. 40 with attached exhibit(s) A B C D filed on 21-NOV-2019
Notice of motion contained within a Motion Record on behalf of Respondent (Apotex Inc.) 1. An Order consented by the parties and attached as schedule A, to this Notice of Motion in writing filed on 21-NOV-2019 DRAFT ORDER received
Written directions of the Court: The Honourable Mr. Justice Webb dated 20-NOV-2019 directing "... As as result of the provision of Rule 47, the power to set aside an order under Rule 399(2) can only be exercised if a motion is brought. The parties are therefore to be adivised that if they wish to pursue this matter, a motion will be required." received on 20-NOV-2019
Draft Order concerning the setting aside of the prohibition Judgment of the Court. received on 15-NOV-2019
Letter from the respondent dated 15-NOV-2019 On consent of all parties Advising the Court that it is necessary for the prohibition order granted by the Judgment be set aside. received on 15-NOV-2019
Traduction certifiée conforme en français des motifs du jugement / doc. # 37 rendu(e)(s) le 18-SEP-2017 déposée le 13-JUN-2019
Traduction certifiée conforme en français du jugement / doc. # 36 rendu(e)(s) le 19-SEP-2017 déposée le 27-SEP-2017 inscrit(e) dans le livre J. & O., volume 306 page(s) 479 - 480
Memorandum to file from the Registry of the FCA dated 19-SEP-2017 transmitting a copy of the Judgment and Reasons for Judgment to Justice Manson, prothonotary Milczynski and the Applications section of the FC placed on file.
Acknowledgment of Receipt received from all parties (by email) with respect to the Direction, Judgment and Reasons of the Court dated September 18, 2017 placed on file on 19-SEP-2017
Reasons for Judgment rendered by The Honourable Madam Justice Gleason concurred in by The Honourable Mr. Justice Webb The Honourable Mr. Justice Near dated 18-SEP-2017 The Court's decision is with regard to Appeal Filed on 19-SEP-2017
Judgment dated 18-SEP-2017 rendered by The Honourable Mr. Justice Webb The Honourable Mr. Justice Near The Honourable Madam Justice Gleason Matter considered with personal appearance The Court's decision is with regard to Appeal Result: granted in part Filed on 19-SEP-2017 entered in J. & O. Book, volume 300 page(s) 272 - 272 (Final decision)
Written directions of the Court: The Honourable Madam Justice Gleason dated 18-SEP-2017 directing " The Court considers the solicitor of record for the respondent to be Nathalie G. Drouin, Deputy Attorney General of Canada." received on 19-SEP-2017
Acknowledgment of Receipt received from all parties by email with respect to the Directions dated August 28, 2017 placed on file on 29-AUG-2017
Written directions of the Court: The Honourable Mr. Justice Webb dated 28-AUG-2017 directing "The request of Apotex Inc. to make further submissions is denied." received on 29-AUG-2017 Confirmed in writing to the party(ies)
Letter from Apotex dated 17-AUG-2017 in response to the Reply submissions Bristol-Myers Squibb received on 17-AUG-2017
Communication from Registry to Judicial Administrator dated 17-AUG-2017 re: forwarding the parties' responses to the Direction of the Court dated 12-JUL-2017.
Supplemental Reply Submissions from Appellants Bristol-Myers Squibb Canada in reply to the Supplemental Submissions of the Respondent's (Apotex) dated 09-AUG-2017 filed on 16-AUG-2017
Submissions on behalf of the respondent in response to the Court Direction (Webb, J.A.) dated July 12, 2017 (ID.60) filed on 09-AUG-2017
Covering letter from Appellant dated 26-JUL-2017 concerning Doc. No. 33 placed on file on 26-JUL-2017
Submisssions on behalf of Appelant in response to Direction of the Court (Webb J.A.) dated 12-JUL-2017 filed on 26-JUL-2017
Acknowledgment of Receipt received from all parties by fax with respect to the Directions of the Court dated July 12, 2017 placed on file on 12-JUL-2017
Written directions of the Court: The Honourable Mr. Justice Webb dated 12-JUL-2017 directing "Since the Supreme Court of Canada released its decision in AstraZeneca Canada Inc. et al. v. Apotex Inc. et al. 2017 SCC 36, on June 30, 2017, the parties will have the right to make additional submissions on this decision provided that: [...]" received on 12-JUL-2017 Confirmed in writing to the party(ies)
Covering letter from the Respondent, Apotex dated 04-JUL-2017 concerning in response to the Appellants' letter dated June 30, 2017. placed on file on 04-JUL-2017
Letter from the appellant dated 30-JUN-2017 re.: Copy of a Decision from S. Court relevant to this Appeal. received on 30-JUN-2017
Loose Case laws submitted at hearing on June 9, 2017 received at hearing on 09-JUN-2017
Appellants Outline of Oral Argument: 898 Patent received at hearing on 09-JUN-2017
This matter comes on for hearing on 09-JUN-2017 at Ottawa before The Honourable Mr. Justice Webb The Honourable Mr. Justice Near The Honourable Madam Justice Gleason Appearances: Mr. Steven Mason, Mr. David Tait, Mrs. Rebecca Crane 416-362-1812 for Appellants Mr. Ben Hackett, Mr. Harry Radomski, Mr. Richard Naiberg, Mr. Sandon Shogilev (416) 979-2211 for the Respondent (Apotex) Mr. Adrien Bieniasiewicz for Respondent (Miniter of Health) Language of Hearing: E Court Usher: Daniel Cormier Duration: on 09-JUN-2017 from 09:30 to 13:05 Courtroom : Federal Court of Appeal Courtroom - Ottawa Court Registrar Catherine Doré Total duration: 3h35min Before the Court: appeal Result: reserved Comments: DARS was used for the hearing. Please note that portion of the hearing is confidential. The Court instructed the registry officer to close the mics during the submissions that were made "in camera" . Please note that the mics were turned off from 9:35 to 9:40 for the confidential submissions. Minutes of Hearing entered in Vol. 223 page(s) 46 - 55 Abstract of Hearing placed on file
Compendium of Apotex Inc. (1 volume) received at hearing on 09-JUN-2017
Compendium of the Appellants (2 volumes) received at hearing on 09-JUN-2017
Letter from Respondent, Apotex dated 08-JUN-2017 in response to the Appellants, BMS' letter dated june 8, 2017 received on 08-JUN-2017
Letter from appellant, BMS dated 08-JUN-2017 with consent of the Respondent, Apotex requesting that this letter be brought to the attention of the panel hearing this appeal which is scheduled to proceed on Friday, June 9, 2017 received on 08-JUN-2017
Letter from the appellant dated 06-JUN-2017 in reply to the Respondent's (AGC) letter dated June 1, 2017 received on 06-JUN-2017
Letter from Respondent Minister of Health dated 01-JUN-2017 In response to the Direction of Webb J.A. dated 15-MAY-2017, the Minister advises that the Notice of Compliance (NOC) has not been issued as of today's date. However, to comment further on the status of the issuance of the NOC as requested by the Court would go beyond the Minister's normal practices and may raise concerns about disclosing confidential information.. Counsel for the Minister will be happy to appear if such attendance is still required. Apotex, Respondent in this proceeding, is in a better position to advise as to the target dates for its own submissions, and to advise the Court should it receive an NOC. received on 01-JUN-2017
Solicitor's certificate of service on behalf of Martin Brandsma confirming service of doc 31 upon Respondent by process server on 29-MAY-2017 filed on 29-MAY-2017
Joint Book of Authorities consisting of 6 volume(s) on behalf of Appellant Filed on 29-MAY-2017 3 copy(ies) for the Court stored in Ottawa
Acknowledgment of Receipt received from all parties (by email) with respect to the Direction of the Court dated May 15, 2017 placed on file on 16-MAY-2017
Affidavit of Darlene Powers on behalf of the respondent - Apotex Inc. sworn on 15-MAY-2017 confirming service of Doc. No. 29 on the appellants and co-respondent by courier on 15-MAY-2017 filed on 15-MAY-2017
Memorandum of fact and law on behalf of the respondent - Apotex Inc. filed on 15-MAY-2017 3 judges' copies stored in Ottawa
Written directions of the Court: The Honourable Mr. Justice Webb dated 15-MAY-2017 directing " The parties are to be notified that it would assist the Court if any compendia that they want to use at the hearing of the appeal are filed as early as possible prior to the hearing of the appeal. Counsel for the Minister of Health should also be informed that the panel requests that such counsel be present at the hearing to advise the Court, to the extent possible, of the status of the issuance of the notice of compliance since this appeal will be rendered moot of this notice is issued prior to a decision being rendred by the Court." received on 15-MAY-2017
Acknowledgements of receipt of the hearing date order: to Ms. Crane (for the Appellants), to Mr. Brodkin (for the Respondent, Apotex Inc.) and to Ms. Campbell (for the Respondent, the Minister of Health - NOT participating) placed on file on 03-MAY-2017
Acknowledgment of Receipt received from all parties (by email) with respect to the Order of the Court dated April 28, 2017 placed on file on 28-APR-2017
Order dated 28-APR-2017 rendered by Chief Justice Noël Matter considered without personal appearance The Court's decision is with regard to Letter from the Respondent (Apotex Inc.) dated 25-APR-2017 Result: "the hearing of this appeal will remain as scheduled on June 9, 2017, at 9:30 a.m. at Ottawa, Ontario." Filed on 28-APR-2017 entered in J. & O. Book, volume 299 page(s) 60 - 61
Letter from Defendant, Apotex Inc. dated 26-APR-2017 in response to the Appellants' letter dated 25-APR-2017; received on 26-APR-2017
Letter from the appellant dated 25-APR-2017 in response to the Respondent's letter dated April 25, 2017, advising that they oppose the request, received on 25-APR-2017
Letter from Defendant, Apotex Inc. dated 25-APR-2017 in response to the Court's Order issued on 25-APR-2017 requesting alternate hearing dates; received on 25-APR-2017
Order (time and place) dated 24-APR-2017 rendered by S. Bazinet, Judicial Administrator and signed by Judicial Administrator fixing Appeal to be heard at Special Sitting in Ottawa on 09-JUN-2017 to begin at 09:30 Filed on 24-APR-2017 cc's sent to parties entered in J. & O. Book, volume 299 page(s) 19 - 19 Transmittal letters placed on file
Letter from the Respondent -Apotex Inc. dated 19-APR-2017 in response to the appellants' letter dated April 18,2017. received on 19-APR-2017
Acknowledgment of Receipt received from all parties with respect to Order of the Court dated April 19, 2017 (doc.26) placed on file on 20-APR-2017
Order dated 19-APR-2017 rendered by The Honourable Madam Justice Gleason Matter considered without personal appearance The Court's decision is with regard to the motion / document number 9 Result: 1-Apotex shall serve and file its memorandum of fact and law on or before May 14, 2017; 2-The appellants shall file the joint book of authorities by May 29, 2017; and 3- this appeal is referred to the Judicial Administrator for scheduling of a hearing in June 2017 in Toronto. Filed on 19-APR-2017 certified copies sent to parties entered in J. & O. Book, volume 299 page(s) 1 - 3
Letter from the appellant dated 18-APR-2017 in response to Reply (doc 20) of the Respondent cocerning R(369) motion. received on 19-APR-2017
Communication from Registry to Judicial Administrator dated 18-APR-2017 re: motion doc 9, response doc.16 and reply doc.20 + ID.29 and 30
Letter from the REspondent, AGC, dated 18-APR-2017 "...The Minister will not be responding to the motion to expedite the appeal..." received on 18-APR-2017
Letter from the respondent dated 17-APR-2017 regarding the Appellants- R. 369 Motion to expedite the within appeal. The respondent is raising a concern at par. 4 of the Appellants reply submissions. received on 18-APR-2017
Solicitor's certificate of service on behalf of Rebecca A. Crane confirming service of Doc. Nos. 23 and 24 upon all parties by process server on 13-APR-2017 filed on 13-APR-2017
Memorandum of fact and law on behalf of Appellants filed on 13-APR-2017 3 judges' copies stored in Ottawa
Appeal Book consisting of 9 volume(s) including confidential volume(s) 4 5 6 7 prepared by Appellants filed on 13-APR-2017 3 judges' copies stored in Ottawa
Solicitor's certificate of service on behalf of Rebecca A. Crane confirming service of Book of Authorities upon all parties by process server on 13-APR-2017 filed on 13-APR-2017
Book of Authorities in Reply (Doc. No. 20) consisting of 1 volume(s) on behalf of Appellants received on 13-APR-2017 1 copy(ies) for the Court stored in Ottawa
Solicitor's certificate of service on behalf of Rebecca A. Crane confirming service of Doc#20 Reply motion record of the appellants upon Respondents by telecopier on 12-APR-2017 filed on 12-APR-2017
Reply Representations contained within a Motion Record on behalf of Appellant in response to in support of doc#6 Appellants motion to expedite appeal Filed on 12-APR-2017
Solicitor's certificate of service on behalf of Sandon Shogilev confirming service of Doc 18 upon Appellant by courier on 11-APR-2017 filed on 11-APR-2017
Book of Authorities consisting of 1 volume(s) on behalf of Apotex Inc., Respondent Filed on 11-APR-2017 1 copy(ies) for the Court stored in Ottawa
Affidavit of Leana Da Silva on behalf of Apotex Inc., Respondent sworn on 10-APR-2017 confirming service of Doc 16 on the appellant by courier on 10-APR-2017 filed on 10-APR-2017
Motion Record in response to Motion Doc. No. 6 containing the following original document(s): 15 Number of copies received: 3 on behalf of Apotex Inc., Respondent filed on 10-APR-2017
Written representations contained within a Motion Record on behalf of Apotex Inc., Respondent in opposition to Doc 6 filed on 10-APR-2017
Affidavit of service of Sonia Atwell on behalf of the appellant sworn on 07-APR-2017 confirming service of doc. #13 on Apotex INc., the Respondent and The Minister of Health, the Respondent by telecopier on 06-APR-2017 with attached exhibit(s) "A" filed on 07-APR-2017
Agreement as to the content of the Appeal book from the appellant the respondent the Respondent AGC filed on 07-APR-2017
Affidavit of Jessica Oliveira on behalf of the respondent sworn on 28-MAR-2017 confirming service of Doc. 11 on the respondent by telecopier on 27-MAR-2017 filed on 28-MAR-2017
Notice of appearance on behalf of Respondent filed on 28-MAR-2017
Solicitor's certificate of service on behalf of Sanjaya Mendis (Appellants) confirming service of Doc 9 & Book of Authorities upon all parties by process server on 29-MAR-2017 filed on 29-MAR-2017
Book of Authorities consisting of 1 volume(s) on behalf of Appellant received on 29-MAR-2017 1 copy(ies) for the Court stored in Ottawa
Motion Record containing the following original document(s): 6 7 8 Number of copies received: 3 on behalf of Appellant filed on 29-MAR-2017
Written representations contained within a Motion Record on behalf of the appellant in support of Motion Doc 6 filed on 29-MAR-2017
Affidavit of Sonia Atwell contained within a Motion Record on behalf of the applicant sworn on 28-MAR-2017 in support of Motion Doc 6 with attached exhibit(s) A - E filed on 29-MAR-2017
Notice of motion contained within a Motion Record on behalf of the appellant an Order to expedite the within appeal; and other relief in writing filed on 29-MAR-2017
Memorandum to file from the FCA Registry dated 29-MAR-2017 forwarding a copy of the Notice of Appeal to the Honourable Justice Manson, to the Applications section of the FC and to Prothonotary Milczynski. placed on file.
Copy of doc.1 with proof of service on Respondent:MOH on 28-MAR-2017 filed on 28-MAR-2017
Affidavit of James Adeney on behalf of The Respondent - The Minister of Health sworn on 27-MAR-2017 confirming service of Doc. # 3 on Appellants and Respondents Apotex Inc. by telecopier on 27-MAR-2017 with attached exhibit(s) "A" filed on 27-MAR-2017
Notice of appearance on behalf of Respondent - The Minister of Health filed on 27-MAR-2017
Affidavit of Sonia Atwell on behalf of the appellant sworn on 27-MAR-2017 confirming service of doc. 1 on the respondents by telecopier on 24-MAR-2017 with attached exhibit(s) A filed on 27-MAR-2017
Notice of Appeal and 2 copies filed on 24-MAR-2017 against a decision OF JUSTICE MANSON DATED 21-MAR-2017 ON FC FILE T-1100-15 Certified copy(ies)/copy(ies) transmitted to Director of the Regional Office of the Department of Justice Tariff fee of $50.00 received: yes
The official version of the court proceeding information is available from the court websites directly: